FAIM
MEDP icon

Financial Advocates Investment Management’s Medpace MEDP Stock Holding History

Financial Advocates Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,237
Closed -$388K – 376
2025
Q2 		$388K Sell
1,237
-67
-5% -$20.1K 0.03% 428
2025
Q1 		$397K Buy
1,304
+31
+2% +$10.4K 0.03% 482
2024
Q4 		$423K Buy
+1,273
New +$432K 0.02% 506

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Financial Advocates Investment Management's MEDP Position: Q3 2025 in Review

Financial Advocates Investment Management sold out of Medpace (MEDP) in Q3 2025, closing a stake of 1,237 shares — an estimated $388K sold.

Financial Advocates Investment Management first reported a position in MEDP in Q4 2024 and held it in 3 quarters. The position peaked at $423K in Q4 2024. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Financial Advocates Investment Management reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Financial Advocates Investment Management sold 1,237 Medpace shares in Q3 2025, an estimated $388K.
  • Financial Advocates Investment Management first reported a position in Medpace in Q4 2024 and held it in 3 quarters.
  • Financial Advocates Investment Management's Medpace position peaked at $423K in Q4 2024.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Financial Advocates Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.